Search

Your search keyword '"Tarnani, Michela"' showing total 161 results
Start Over Author "Tarnani, Michela"
161 results on '"Tarnani, Michela"'

1. Nursing Management of Frail Patients with Hematologic Malignancies During COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021

Author

Ciambella, Silvia, primary, Innocenti, Vincenza, additional, Cippitelli, Elisa Emanueli, additional, Perazzino, Roberta, additional, Talucci, Roberta, additional, Panichi, Valentina, additional, Fiorini, Alessia, additional, Di Veroli, Ambra, additional, Mercanti, Caterina, additional, Natalino, Fiammetta, additional, De Angelis, Gioia, additional, Tarnani, Michela, additional, Morucci, Marco, additional, Mastini, Cristina, additional, Trapè, Giulio, additional, Silvestri, Assunta, additional, Montanaro, Marco, additional, and Latagliata, Roberto, additional

Published
2024
Full Text
View/download PDF

2. Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience

Author

Innocenti, Idanna, primary, Fresa, Alberto, additional, Tomasso, Annamaria, additional, Tarnani, Michela, additional, De Padua, Laura, additional, Benintende, Giulia, additional, Pasquale, Raffaella, additional, Galli, Eugenio, additional, Morelli, Francesca, additional, Giannarelli, Diana, additional, Autore, Francesco, additional, and Laurenti, Luca, additional

Published
2023
Full Text
View/download PDF

3. Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents

Author

Scamuffa, Maria Cristina, primary, Latagliata, Roberto, additional, Carmosino, Ida, additional, Di Veroli, Ambra, additional, Scalzulli, Emilia, additional, Trapè, Giulio, additional, Ciotti, Giulia, additional, De Angelis, Gioia, additional, Tartaglia, Germana, additional, Tarnani, Michela, additional, Breccia, Massimo, additional, and Girmenia, Corrado, additional

Published
2023
Full Text
View/download PDF

4. Treatment in patients with acute myeloid leukemia/high‐risk myelodysplastic syndrome with hypomethylating agents: Day‐hospital management compared to home care setting

Author

Trapè, Giulio, primary, De Angelis, Gioia, additional, Morucci, Marco, additional, Tarnani, Michela, additional, De Gregoris, Cinzia, additional, Di Veroli, Ambra, additional, Panichi, Valentina, additional, Topini, Giuseppe, additional, Bassi, Loredana, additional, Isidori, Raffaella, additional, Poscente, Monica, additional, Innocenti, Vincenza, additional, Cippitelli, Elisa Emanueli, additional, Talucci, Roberta, additional, Bertelli, Silvia, additional, Crocicchia, Alessandra, additional, Lippi, Annalisa, additional, Pezzuti, Giulia, additional, Fuschino, Michela, additional, Randi, Raffaella, additional, Mastini, Cristina, additional, Ciambella, Silvia, additional, Pessina, Gloria, additional, Montanaro, Marco, additional, and Latagliata, Roberto, additional

Published
2023
Full Text
View/download PDF

5. Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience

Author

Innocenti, Idanna, Fresa, Alberto, Tomasso, Annamaria, Tarnani, Michela, De Padua, L., Benintende, G., Pasquale, R., Galli, Eugenio, Morelli, F., Giannarelli, Diana, Autore, Francesco, Laurenti, Luca, Innocenti I., Fresa A., Tomasso A., Tarnani M., Galli E., Giannarelli D., Autore F., Laurenti L. (ORCID:0000-0002-8327-1396), Innocenti, Idanna, Fresa, Alberto, Tomasso, Annamaria, Tarnani, Michela, De Padua, L., Benintende, G., Pasquale, R., Galli, Eugenio, Morelli, F., Giannarelli, Diana, Autore, Francesco, Laurenti, Luca, Innocenti I., Fresa A., Tomasso A., Tarnani M., Galli E., Giannarelli D., Autore F., and Laurenti L. (ORCID:0000-0002-8327-1396)

Abstract

Background: This monocentric retrospective study describes the treatment patterns and outcomes of chronic lymphocytic leukemia (CLL) patients. Methods: Adult CLL patients treated between 1992 and 2022 were included. The time to next treatment (TTNT) was defined as the time from the treatment’s start to the start of a subsequent therapy or death. The time to next treatment failure or death (TTNTF) was defined as the time from treatment discontinuation to the discontinuation of a subsequent therapy or death. Results: Of 637 registered patients, 318 (49.9%) received treatment. We evaluated 157 cBTKi-exposed, 34 BCL2i-exposed cBTKi-naïve, and 26 double-exposed patients. The five-year TTNT values in the cBTKi-exposed patients were 80% (median NR), 40% (median 40 months), and 21% (median 24 months) months in the first line (1L), second line (2L), and beyond the second line (>2L), respectively (p < 0.0001). The five-year TTNT values in the BCL2i-exposed patients were 83% (median NR), 72% (median NR), 12% (median 28 months) in the 1L, 2L, and >2L, respectively (p = 0.185). The median TTNTF was 9 months (range 1–87) after cBTKi and 17 months (range 8–49) after both a cBTKi and BCL2i. Conclusions: This study suggests that, in CLL patients, the earlier we used targeted therapies, the better was the outcome obtained. Nonetheless, the poor outcomes in the advanced lines of therapy highlight the need for more effective treatments.

Published
2023

6. Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022

Author

Emanueli Cippitelli, Elisa, primary, Innocenti, Vincenza, additional, De Angelis, Gioia, additional, Bertelli, Silvia, additional, Talucci, Roberta, additional, Perazzini, Roberta, additional, Burla, Roberta, additional, Panichi, Valentina, additional, Topini, Giuseppe, additional, Di Veroli, Ambra, additional, Fiorini, Alessia, additional, Mercanti, Caterina, additional, Natalino, Fiammetta, additional, Stefanizzi, Caterina, additional, De Gregoris, Cinzia, additional, Tarnani, Michela, additional, Morucci, Marco, additional, Mastino, Cristina, additional, Trapè, Giulio, additional, Montanaro, Marco, additional, Latagliata, Roberto, additional, and Ciambella, Silvia, additional

Published
2022
Full Text
View/download PDF

8. Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021

Author

Ciambella, Silvia, primary, Innocenti, Vincenza, additional, Emanueli Cippitelli, Elisa, additional, Bertelli, Silvia, additional, Talucci, Roberta, additional, Panichi, Valentina, additional, Topini, Giuseppe, additional, Fiorini, Alessia, additional, Di Veroli, Ambra, additional, Mercanti, Caterina, additional, Natalino, Fiammetta, additional, De Angelis, Gioia, additional, Tarnani, Michela, additional, Morucci, Marco, additional, Mastino, Cristina, additional, Stagno, Fabio, additional, Trapè, Giulio, additional, Silvestri, Assunta, additional, Montanaro, Marco, additional, and Latagliata, Roberto, additional

Published
2021
Full Text
View/download PDF

9. Azacytidine Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome: Day-Hospital Management Compared to Home Care Setting

Author

Trapè, Giulio, primary, De Angelis, Gioia, additional, Morucci, Marco, additional, Tarnani, Michela, additional, De Gregoris, Cinzia, additional, Di Veroli, Ambra, additional, Panichi, Valentina, additional, Topini, Giuseppe, additional, Bassi, Loredana, additional, Isidori, Raffaella, additional, Poscente, Monica, additional, Innocenti, Vincenza, additional, Emanueli Cippitelli, Elisa, additional, Talucci, Roberta, additional, Bertelli, Silvia, additional, Crocicchia, Alessandra, additional, Lippi, Annalisa, additional, Pezzuti, Giulia, additional, Fuschino, Michela, additional, Randi, Raffaella, additional, Mastino, Cristina, additional, Ciambella, Silvia, additional, Pessina, Gloria, additional, Montanaro, Marco, additional, and Latagliata, Roberto, additional

Published
2021
Full Text
View/download PDF

11. Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report

Author

De Angelis, Gioia, Fiorini, Alessia, Trapè, Giulio, Panichi, Valentina, Chavez, Maria Gabriela, Emanueli Cippitelli, Elisa, Innocenti, Vincenza, Perazzini, Roberta, Talucci, Roberta, Topini, Giuseppe, Di Veroli, Ambra, Mercanti, Caterina, Natalino, Fiammetta, Tarnani, Michela, Morucci, Marco, Mastini, Cristina, Silvestri, Assunta, Andriani, Alessandro, Montanaro, Marco, Ciambella, Silvia, and Latagliata, Roberto

Published
2023
Full Text
View/download PDF

12. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome

Author

Laurenti, Luca, De Padua, Laura, Tarnani, Michela, Piccirillo, Nicola, Falcucci, Paolo, D’Arena, Giovanni, Innocenti, Idanna, Marietti, Sara, Efremov, Dimitar G., Chiusolo, Patrizia, Zini, Gina, Sora’, Federica, Sica, Simona, and Leone, Giuseppe

Published
2011
Full Text
View/download PDF

15. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

Author

Laurenti, Luca, Tarnani, Michela, Nichele, Ilaria, Ciolli, Stefania, Cortelezzi, Agostino, Forconi, Francesco, Rossi, Davide, Mauro, Francesca Romana, DʼArena, Giovanni, Del Poeta, Giovanni, Montanaro, Marco, Morabito, Fortunato, Musolino, Caterina, Callea, Vincenzo, Falchi, Lorenzo, Tedeschi, Alessandra, Ambrosetti, Achille, Gaidano, Gianluca, Leone, Giuseppe, and Foà, Robin

Published
2011
Full Text
View/download PDF

25. New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia

Author

Laurenti, Luca, De Padua, Laura, D'Arena, G, Vannata, Barbara, Innocenti, Idanna, Tarnani, Michela, Deaglio, S, Sica, Simona, Efremov, Dg, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Sica, Simona (ORCID:0000-0003-2426-3465), Laurenti, Luca, De Padua, Laura, D'Arena, G, Vannata, Barbara, Innocenti, Idanna, Tarnani, Michela, Deaglio, S, Sica, Simona, Efremov, Dg, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), and Sica, Simona (ORCID:0000-0003-2426-3465)

Abstract

Over the last few years, several new agents have been under evaluation in preclinical studies and clinical trials, showing promise in treating chronic lymphocytic leukemia (CLL). Among these agents, monoclonal antibodies (mAbs) such as rituximab and alemtuzumab have changed the natural course of the disease. Nowadays there are several new promising monoclonal antibodies under investigation against the CD20, CD23, CD37 and CD40 molecules. Application of newer monoclonal antibodies represents an area of ongoing clinical research in CLL.

Published
2011

26. Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience

Author

Laurenti, Luca, Chiusolo, Patrizia, Tarnani, Michela, Balducci, Mario, Piccirillo, Nicola, Sora', Federica, Sica, Simona, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Balducci, Mario (ORCID:0000-0003-0398-9726), Piccirillo, Nicola (ORCID:0000-0002-1688-1987), Sora', Federica (ORCID:0000-0002-9607-5298), Sica, Simona (ORCID:0000-0003-2426-3465), Laurenti, Luca, Chiusolo, Patrizia, Tarnani, Michela, Balducci, Mario, Piccirillo, Nicola, Sora', Federica, Sica, Simona, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Balducci, Mario (ORCID:0000-0003-0398-9726), Piccirillo, Nicola (ORCID:0000-0002-1688-1987), Sora', Federica (ORCID:0000-0002-9607-5298), and Sica, Simona (ORCID:0000-0003-2426-3465)

Abstract

Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience.

Published
2011

27. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease

Author

D'Arena, G, Laurenti, Luca, Minervini, Mm, Deaglio, S, Bonello, L, De Martino, L, De Padua, Laura, Savino, L, Tarnani, Michela, De Feo, V, Cascavilla, N., Laurenti, Luca (ORCID:0000-0002-8327-1396), D'Arena, G, Laurenti, Luca, Minervini, Mm, Deaglio, S, Bonello, L, De Martino, L, De Padua, Laura, Savino, L, Tarnani, Michela, De Feo, V, Cascavilla, N., and Laurenti, Luca (ORCID:0000-0002-8327-1396)

Abstract

Regulatory T-cells (Treg) actively maintain immunological self-tolerance and play a significant role in the progression of cancer. Treg cell numbers have been evaluated in 80 patients with previously untreated chronic lymphocytic leukemia (CLL) and in 40 normal healthy volunteers. Treg cells are higher in CLL patients than in controls and correlate with disease status (more advanced clinical stage, peripheral blood B-cell lymphocytosis, absolute CD38+ B-cell number, and more elevated LDH levels). No correlation was found with ZAP-70 expression, IgVH mutational status and cytogenetic abnormalities. This data shows that Treg cell number is abnormal in CLL patients.

Published
2011

28. Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients

Author

Palladino, Michele, Laurenti, Luca, Chiusolo, Patrizia, Piccioni, Paola, Innocenti, Idanna, Tarnani, Michela, Sora', Federica, Sica, Simona, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Sora', Federica (ORCID:0000-0002-9607-5298), Sica, Simona (ORCID:0000-0003-2426-3465), Palladino, Michele, Laurenti, Luca, Chiusolo, Patrizia, Piccioni, Paola, Innocenti, Idanna, Tarnani, Michela, Sora', Federica, Sica, Simona, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Sora', Federica (ORCID:0000-0002-9607-5298), and Sica, Simona (ORCID:0000-0003-2426-3465)

Abstract

Few data are available to date on the dose of oral valganciclovir as cytomegalovirus (CMV) preemptive therapy in stem cell transplantation patients. This study aimed to evaluate the efficacy and safety of low-dose valganciclovir (900 mg/day) as preemptive treatment in allotransplanted recipients. Valganciclovir was used in 34 patients who underwent allogeneic stem cell transplantation for hematological malignancies at the dose of 900 mg oral administration/day (12 patients, group 1) or 1,800 mg oral administration/day (22 patients, group 2). Thirty-two out of 34 patients (94%) obtained negativization of polymerase chain reaction for CMV at a median of 12.5 days from the beginning of valganciclovir administration (10/12 patients of group 1, 22/22 patients of group 2). We conclude that oral administration of valganciclovir can induce clearance of CMV viral load in about 2 weeks; moreover, lower-dose oral valganciclovir (900 mg/day) has a comparable efficacy to the proposed standard dose (1,800 mg/day).

Published
2010

29. Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia.

Author

Luigetti, Marco, Frisullo, Giovanni, Laurenti, Luca, Conte, Amelia, Madia, Francesca, Profice, Paolo, Batocchi, Anna Paola, Montano, Nicola, Tarnani, Michela, Tonali, Pietro Attilio, Sabatelli, Mario, Luigetti, Marco (ORCID:0000-0001-7539-505X), Laurenti, Luca (ORCID:0000-0002-8327-1396), Montano, Nicola (ORCID:0000-0002-4965-1950), Sabatelli, Mario (ORCID:0000-0001-6635-4985), Luigetti, Marco, Frisullo, Giovanni, Laurenti, Luca, Conte, Amelia, Madia, Francesca, Profice, Paolo, Batocchi, Anna Paola, Montano, Nicola, Tarnani, Michela, Tonali, Pietro Attilio, Sabatelli, Mario, Luigetti, Marco (ORCID:0000-0001-7539-505X), Laurenti, Luca (ORCID:0000-0002-8327-1396), Montano, Nicola (ORCID:0000-0002-4965-1950), and Sabatelli, Mario (ORCID:0000-0001-6635-4985)

Abstract

Waldenström's macroglobulinaemia is a form of monoclonal IgM gammopathy associated with a rare B-cell lympho-plasmacytic lymphoma, characterized by the involvement of bone marrow, lymph nodes and spleen. Neurological complications involving peripheral nerves are common and different pathogenic mechanisms have been reported. We describe a patient with severe multineuropathy associated with Waldenström's macroglobulinaemia. Nerve biopsy revealed copious light chain deposition which subverted the normal architecture of the endoneurium and epineurium resulting in massive fascicular hyalinosis and epineural arteries disruption, respectively. This report confirms that massive immunoglobulin deposition is one of the several mechanisms of nerve damage in IgM-related neuropathy. Since their recognition has important therapeutical consequences, nerve biopsy is an essential diagnostic tool in patients with an unusual clinical presentation of IgM-related neuropathies. Copyright © 2010 Elsevier B.V. All rights reserved.

Published
2010

30. Neurologic improvement after peripheral blood stem cell transplantation in poems

Author

Sabatelli, Mario, Luigetti, Marco, Laurenti, Luca, Conte, Andrea, Madia, Francesca, De Matteis, Silvia, Chiusolo, Patrizia, Tarnani, Michela, Sica, Simona, Sabatelli, Mario (ORCID:0000-0001-6635-4985), Luigetti, Marco (ORCID:0000-0001-7539-505X), Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Sica, Simona (ORCID:0000-0003-2426-3465), Sabatelli, Mario, Luigetti, Marco, Laurenti, Luca, Conte, Andrea, Madia, Francesca, De Matteis, Silvia, Chiusolo, Patrizia, Tarnani, Michela, Sica, Simona, Sabatelli, Mario (ORCID:0000-0001-6635-4985), Luigetti, Marco (ORCID:0000-0001-7539-505X), Laurenti, Luca (ORCID:0000-0002-8327-1396), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), and Sica, Simona (ORCID:0000-0003-2426-3465)

Abstract

We read with interest the recent article by Kuwabara et al.1 describing the clinical and electrophysiologic findings in 9 patients with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome and treated with autologous peripheral blood stem cell transplantation (auto-PBSCT). From May 2003 until September 2006, we treated 4 patients with POEMS syndrome with chemotherapy and auto-PBSCT.2 There were 3 men and 1 woman with a median age of 53 years (range 44–62). Three patients had severe and rapidly progressive sensory– motor peripheral neuropathy with predominant involvement of the lower limbs leading to inability to walk, reduced muscle strength of the upper limbs, absent deep tendon reflexes, and distal sensory impairment.

Published
2009

31. Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.

Author

Laurenti, Luca, Tarnani, Michela, Innocenti, Idanna, Savino, Gustavo, Battendieri, Remo, Larocca, Luigi Maria, Chiusolo, Patrizia, Sora', Federica, Sica, Simona, Efremov, Dg, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Savino, Gustavo (ORCID:0000-0002-9993-5986), Larocca, Luigi Maria (ORCID:0000-0003-1739-4758), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Sora', Federica (ORCID:0000-0002-9607-5298), Sica, Simona (ORCID:0000-0003-2426-3465), Efremov , Dg, Laurenti, Luca, Tarnani, Michela, Innocenti, Idanna, Savino, Gustavo, Battendieri, Remo, Larocca, Luigi Maria, Chiusolo, Patrizia, Sora', Federica, Sica, Simona, Efremov, Dg, Leone, Giuseppe, Laurenti, Luca (ORCID:0000-0002-8327-1396), Savino, Gustavo (ORCID:0000-0002-9993-5986), Larocca, Luigi Maria (ORCID:0000-0003-1739-4758), Chiusolo, Patrizia (ORCID:0000-0002-1355-1587), Sora', Federica (ORCID:0000-0002-9607-5298), Sica, Simona (ORCID:0000-0003-2426-3465), and Efremov , Dg

Published
2008

34. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia

Author

Bulian, Pietro, primary, Tarnani, Michela, additional, Rossi, Davide, additional, Forconi, Francesco, additional, Del Poeta, Giovanni, additional, Bertoni, Francesco, additional, Zucca, Emanuele, additional, Montillo, Marco, additional, Pozzato, Gabriele, additional, Deaglio, Silvia, additional, D'Arena, Giovanni, additional, Efremov, Dimitar, additional, Marasca, Roberto, additional, Lauria, Francesco, additional, Gattei, Valter, additional, Gaidano, Gianluca, additional, and Laurenti, Luca, additional

Published
2011
Full Text
View/download PDF

36. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients

Author

D’Arena, Giovanni, primary, Capalbo, Silvana, additional, Laurenti, Luca, additional, Del Poeta, Giovanni, additional, Nunziata, Giuseppe, additional, Deaglio, Silvia, additional, Spinosa, Giuseppina, additional, Tarnani, Michela, additional, De Padua, Laura, additional, Califano, Catello, additional, Ferrara, Felicetto, additional, and Cascavilla, Nicola, additional

Published
2010
Full Text
View/download PDF

38. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome

Author

Laurenti, Luca, primary, De Padua, Laura, additional, Tarnani, Michela, additional, Piccirillo, Nicola, additional, Falcucci, Paolo, additional, D’Arena, Giovanni, additional, Innocenti, Idanna, additional, Marietti, Sara, additional, Efremov, Dimitar G., additional, Chiusolo, Patrizia, additional, Zini, Gina, additional, Sora’, Federica, additional, Sica, Simona, additional, and Leone, Giuseppe, additional

Published
2010
Full Text
View/download PDF

39. Circulating hematopoietic progenitor cells after autologous stem cell transplant for hematological malignancies

Author

Piccirillo, Nicola, primary, De Matteis, Silvia, additional, Ausoni, Giuseppe, additional, Laurenti, Luca, additional, Tarnani, Michela, additional, Chiusolo, Patrizia, additional, Fancello, Giovanni, additional, Rumi, Gabriele, additional, Sorà, Federica, additional, D'onofrio, Giuseppe, additional, Leone, Giuseppe, additional, and Sica, Simona, additional

Published
2010
Full Text
View/download PDF

42. Multivariate Analysis of Prognostic Factors in CLL: A Study on 431 Patients Showing Usefulness of Novel Biological and Old Clinical Parameters in Predicting Shorter Survival: An Italian Multicentric Study

Author

Laurenti, Luca, primary, Tarnani, Michela, primary, Bulian, Pietro, primary, Gaidano, Gianluca, primary, Rossi, Davide, primary, Forconi, Francesco, primary, Deaglio, Silvia, primary, Bertoni, Francesco, primary, Efremov, Dimitar G, primary, Marasca, Roberto, primary, Poeta, Giovanni Del, primary, Malavasi, Fabio, primary, and Gattei, Valter, primary

Published
2008
Full Text
View/download PDF

46. Germline IgVH, del(17p13.1) and del(11q22.3) Predict Duration of Response in Patients Affected by Chronic Lymphocytic Leukaemia Treated with Oral Fludarabine and Cyclophosphamide as First-Line Therapy.

Author

Laurenti, Luca, primary, Efremov, Dimitar, additional, Tarnani, Michela, additional, de Padua, Laura, additional, Piccirillo, Nicola, additional, Chiusolo, Patrizia, additional, Sora’, Federica, additional, Sica, Simona, additional, Zini, Gina, additional, Garzia, Mariagrazia, additional, and Leone, Giuseppe, additional

Published
2007
Full Text
View/download PDF

49. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia

Author

D'Arena, Giovanni, primary, Tarnani, Michela, additional, Rumi, Carlo, additional, Vaisitti, Tiziana, additional, Aydin, Semra, additional, De Filippi, Rosaria, additional, Perrone, Francesco, additional, Pinto, Antonio, additional, Chiusolo, Patrizia, additional, Deaglio, Silvia, additional, Malavasi, Fabio, additional, and Laurenti, Luca, additional

Published
2007
Full Text
View/download PDF

50. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia

Author

D'Arena, Giovanni, primary, Laurenti, Luca, additional, Capalbo, Silvana, additional, D'Arco, Alfonso Maria, additional, De Filippi, Rosaria, additional, Marcacci, Gianpaolo, additional, Di Renzo, Nicola, additional, Storti, Sergio, additional, Califano, Catello, additional, Vigliotti, Maria Luigia, additional, Tarnani, Michela, additional, Ferrara, Felicetto, additional, and Pinto, Antonio, additional

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results